Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- STUDY: 63 Per Cent of Canadians Have Bought Refurbished, Open Box or Traded in Technology in the Past Year, Driven by Cost, Environmental Impact, and Product ValueVANCOUVER, British Columbia, August 17, 2026--Ahead of back-to-school, one of the largest shopping moments for electronics, Canadians are rethinking what "new" means to them when buying tech. A new report from Best Buy Canada found that 63 per cent of Canadians have purchased refurbished, open box or traded in devices in the past year, but openness varies by generation, pointing to a growing divide in how Canadians purchase technology and what draws them to supporting the circular economy in the
- 2-Day Virtual Seminar: Practical ICH Q10 Pharmaceutical Quality System (PQS) Implementation for FDA Compliance & Inspection Readiness (August 26–27, 2026)Designed to help pharmaceutical and biotechnology organizations navigate evolving global regulatory expectations from the FDA, EMA, and MHRA, this intensive 2-day virtual seminar delivers practical strategies for designing, implementing, maintaining, and continually improving a robust Pharmaceutical Quality System (PQS). The course covers essential PQS frameworks based on ICH Q10 and ICH Q9(R1) Quality Risk Management, focusing on key operational components including Corrective and Preventive Action (CAPA) systems, change control, supplier quality management, process performance and product quality monitoring, and audit readiness to prevent compliance gaps.
- International Petroleum Corporation Announces Results of Normal Course Issuer BidInternational Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 205,334 IPC common shares (ISIN: CA46016U1084) during the period of August 10 to 14, 2026 under IPC’s previously announced normal course issuer bid / share repurchase program (NCIB).
- CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine PipelineOn August 16, 2026, CanSino Biologics Inc. ("CanSinoBIO"; HKEX: 06185/SHSE: 688185) announced that the New Drug Application (NDA) for its Tetanus, Reduced Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine, Adsorbed (for people aged six years and above; the "Td5cp Adolescent and Adult") has been formally accepted by China's National Medical Products Administration (NMPA). As a booster vaccine for adolescents and adults, the product was granted Priority Review status in May 2026. If approved and launched, it is expected to create synergies with the recently approved next-generation three-component DTaP vaccine Tripecia(R) (DT3cP Infant), further strengthening CanSinoBIO's pertussis-containing vaccine portfolio across different age groups. Pertussis is a highly contagious acute respiratory infectious disease caused by Bordetella pertussis¹. In recent years, the disease has experienced a global resurgence. Data show that reported pertussis cases in China exceeded 470,000 in 2024¹, representing an approximately 12-fold increase compared with 2023 and drawing sustained attention to disease prevention and control. Against this backdrop, in addition to primary immunization in infants, the importance of booster immunization during adolescence and adulthood has become increasingly evident. Vaccination with diphtheria, tetanus and pertussis-containing vaccines is an important measure for preventing the related diseases, yet China has long lacked a dedicated booster immunization product for people aged six years and above. In April this year, CanSinoBIO's Diphtheria, Tetanus and Pertussis (Acellular, Three Components) Combined Vaccine, Adsorbed for infants—Tripecia(R) (DT3cP Infant)—was approved for marketing through the NMPA's Priority Review pathway, marking an important breakthrough for the company in component-based pertussis vaccine technology. Compared with the three-component (PT, FHA and PRN) DT3cP vaccine, the Td5cp Adolescent and Adult includes two additional pertussis antigens, FIM2 and FIM3. Each pertussis antigen is individually purified and formulated at precise ratios, helping ensure stable product quality and batch-to-batch consistency. The continued advancement of this product will also support further exploration of innovative component-based pertussis vaccine technology across broader age groups. In July 2026, seven departments, including the National Disease Control and Prevention Administration and the National Development and Reform Commission, jointly issued the "15th Five-Year Plan for Disease Prevention and Control", which explicitly calls for the implementation of a life-course immunization strategy covering the entire population. As public health needs continue to evolve, providing more comprehensive immunization protection solutions for people at different stages of life has become an important direction for vaccine innovation. If the Td5cp Adolescent and Adult is successfully approved and launched, it will further enrich CanSinoBIO's pertussis-containing vaccine portfolio and support the company's continued efforts to strengthen its innovative vaccine portfolio across all age groups. From a capital market perspective, the acceptance of the NDA for the Td5cp Adolescent and Adult marks the product's formal entry into a key regulatory review stage. It also represents important progress in CanSinoBIO's continued advancement of innovative vaccine R&D and commercialization, while strengthening market expectations for the development of the company's pipeline of combination vaccine candidates and laying a solid foundation for the company's medium- to long-term performance growth. References: 1. Chinese Center for Disease Control and Prevention: https://www.chinacdc.cn/jkyj/mygh02/jbzt/xjxcrb/brk/202409/t20240925_300997.html 2. Zhang W, Wei C, Wan P, et al. Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China. Emerg Microbes Infect. 2026 Feb;15(1):2625556. 3. Dai H, Sui X, Che J, et al. Pathogenicity and vaccine protection of circulating pertactin- and filamentous hemagglutinin-deficient Bordetella pertussis strains. Emerg Microbes Infect. 2026 Feb;15(1):2640283. 4. CSR data on file
- CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine PipelineOn August 16, 2026, CanSino Biologics Inc. ("CanSinoBIO"; HKEX: 06185/SHSE: 688185) announced that the New Drug Application (NDA) for its Tetanus, Reduced Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine, Adsorbed (for people aged six years and above; the "Td5cp Adolescent and Adult") has been formally accepted by China's National Medical Products Administration (NMPA). As a booster vaccine for adolescents and adults, the product was granted Priority Review status in May 2026. If approved and launched, it is expected to create synergies with the recently approved next-generation three-component DTaP vaccine Tripecia(R) (DT3cP Infant), further strengthening CanSinoBIO's pertussis-containing vaccine portfolio across different age groups. Pertussis is a highly contagious acute respiratory infectious disease caused by Bordetella pertussis¹. In recent years, the disease has experienced a global resurgence. Data show that reported pertussis cases in China exceeded 470,000 in 2024¹, representing an approximately 12-fold increase compared with 2023 and drawing sustained attention to disease prevention and control. Against this backdrop, in addition to primary immunization in infants, the importance of booster immunization during adolescence and adulthood has become increasingly evident. Vaccination with diphtheria, tetanus and pertussis-containing vaccines is an important measure for preventing the related diseases, yet China has long lacked a dedicated booster immunization product for people aged six years and above. In April this year, CanSinoBIO's Diphtheria, Tetanus and Pertussis (Acellular, Three Components) Combined Vaccine, Adsorbed for infants—Tripecia(R) (DT3cP Infant)—was approved for marketing through the NMPA's Priority Review pathway, marking an important breakthrough for the company in component-based pertussis vaccine technology. Compared with the three-component (PT, FHA and PRN) DT3cP vaccine, the Td5cp Adolescent and Adult includes two additional pertussis antigens, FIM2 and FIM3. Each pertussis antigen is individually purified and formulated at precise ratios, helping ensure stable product quality and batch-to-batch consistency. The continued advancement of this product will also support further exploration of innovative component-based pertussis vaccine technology across broader age groups. In July 2026, seven departments, including the National Disease Control and Prevention Administration and the National Development and Reform Commission, jointly issued the "15th Five-Year Plan for Disease Prevention and Control", which explicitly calls for the implementation of a life-course immunization strategy covering the entire population. As public health needs continue to evolve, providing more comprehensive immunization protection solutions for people at different stages of life has become an important direction for vaccine innovation. If the Td5cp Adolescent and Adult is successfully approved and launched, it will further enrich CanSinoBIO's pertussis-containing vaccine portfolio and support the company's continued efforts to strengthen its innovative vaccine portfolio across all age groups. From a capital market perspective, the acceptance of the NDA for the Td5cp Adolescent and Adult marks the product's formal entry into a key regulatory review stage. It also represents important progress in CanSinoBIO's continued advancement of innovative vaccine R&D and commercialization, while strengthening market expectations for the development of the company's pipeline of combination vaccine candidates and laying a solid foundation for the company's medium- to long-term performance growth. References: 1. Chinese Center for Disease Control and Prevention: https://www.chinacdc.cn/jkyj/mygh02/jbzt/xjxcrb/brk/202409/t20240925_300997.html 2. Zhang W, Wei C, Wan P, et al. Safety and immunogenicity of diphtheria, tetanus and pertussis (acellular, three components) combined vaccine, adsorbed after three-dose priming in 2 months age infants: a randomized, blinded, controlled phase III clinical trial in China. Emerg Microbes Infect. 2026 Feb;15(1):2625556. 3. Dai H, Sui X, Che J, et al. Pathogenicity and vaccine protection of circulating pertactin- and filamentous hemagglutinin-deficient Bordetella pertussis strains. Emerg Microbes Infect. 2026 Feb;15(1):2640283. 4. CSR data on file
- The King Center and Divine Nine Launch Historic Fundraising Campaign to Preserve Critical History and Amplify Nonviolence365® Ahead of King100The Martin Luther King, Jr. Center for Nonviolent Social Change, in partnership with the National Pan-Hellenic Council (NPHC), announced #D9StrongerTogether, a unified fundraising campaign mobilizing members of all nine historically Black Greek-letter organizations to preserve The King Center's critical history and archives, deepen its nonviolence education and training, and champion the Center's continued work as it approaches King100, the multi-year celebration marking the 100th birthdays of Mrs. Coretta Scott King in 2027 and Dr. Martin Luther King, Jr. in 2029. The King Center's archives are home to the largest collection of primary source materials on Dr. Martin Luther King, Jr., Mrs. Coretta Scott King, and the Civil Rights Movement related to their leadership.
- The Battery NetworkThe Battery Network and National Waste & Recycling Association/Foundation Partner to Advance Battery Safety Education and Recovery Across the U.S.Strategic collaboration will expand education, battery collection initiatives and resources to help the waste and recycling industry safely manage the growing volume of end-of-life batteries The Battery Network along with the National Waste & Recycling Association (NWRA) and the National Waste & Recycling Foundation (NWRF) today announced a strategic partnership to strengthen battery safety educatio
- The Commit PartnershipDallas County Schools Show Continued Progress in 2026 Accountability RatingsResults provide an updated look at student outcomes across Dallas County, with more campuses earning A or B ratings and fewer receiving D or F ratings — The Texas Education Agency (https://tea.texas.gov/) today released its 2026 A–F Accountability...
- HimplantHimplant® Global Surgeon Training Course: 18 Surgeons From Five CountriesHimplant® announced the successful completion of its Global Surgeon Training Course, held May 2026, bringing together 18 surgeons from the United States, Mexico, Colombia, Saudi Arabia and Chile. The three-day program gave participating...
- Nerdy Inc.Nerdy Inc. Announces 1-For-15 Reverse Stock SplitST. LOUIS, August 14, 2026--Nerdy Inc. (NYSE: NRDY), a leading platform for delivering live online learning, today announced that a 1-for-15 reverse stock split of the Company’s Class A Common Stock and Class B Common Stock is expected to become effective at 12:01 a.m.
- NVIDIAUniversitas Gadjah Mada, Indosat and NVIDIA Open Indonesia’s First University AI Center to Develop Local AI TalentCompanies: NvidiaIndonesia is taking charge of its AI future. This week, the Ministry of Communication and Digital Affairs (Komdigi), Indosat Ooredoo Hutchison (Indosat or IOH), NVIDIA and Universitas Gadjah Mada (UGM) launched the UGM Indosat NVIDIA AI Technology Center (NVAITC) in Yogyakarta — the country’s first university-based AI technology center. Established under Indonesia’s AI Center of […]
- FWD Group marks 13 years with charitable grants benefitting over 13,000 people across AsiaFWD Group Holdings Limited (“FWD Group” or “FWD”) today marked its 13th anniversary by announcing charitable grants dedicated to supporting more than 13,000 people in communities across Asia. Established in 2013 with a mission to move the life insurance industry in a new direction, FWD Group has grown from its early operations in Hong Kong SAR, Macau SAR and Thailand into a pan-Asian life and health insurer serving millions of customers and their families across 10 markets. In July last year, FWD Group reached another milestone with its listing on the Hong Kong Stock Exchange, under the stock code 1828. Huynh Thanh Phong, Group Chief Executive Officer and Executive Director of FWD Group, said, “At FWD Group, changing the way people feel about insurance is about much more than looking after our customers – it’s also about supporting the communities where we operate. These 13 grants are a meaningful way to give back to the people and places that have been part of our journey. Together with trusted community partners, we hope to make a real difference in people’s lives, while also bringing our caring value to life through employee volunteering.” The 13 grants will support initiatives across the region spanning financial literacy, career readiness, entrepreneurship, health and wellbeing, and community recovery: - Hong Kong SAR: Extending the JA SparktheDream Wellness Programme with Junior Achievement Hong Kong through interactive workshops and family activities to equip 2,600 primary school students with social, emotional and financial skills to build resilience and thrive. Strengthening the wellbeing, resilience and social-emotional skills of 200 children and 80 caregivers affected by the Tai Po fire through a football-based programme with Save the Children Hong Kong. Advancing the long-term recovery of Tai Po communities with psychosocial support and community-building initiatives led by Plan International Hong Kong for over 6,500 students, parents and teachers. - Cambodia: Equipping 200 young people with practical money management skills via financial education workshops, expert-led discussions and digital learning content with JCI Mekong. - Indonesia: Partnering with KUMPUL on InnovateHer Academy 4.0 to empower another 10 female entrepreneurs with mentorship, business and investment readiness skills. - Japan: Promoting inclusion, wellbeing and social connection through football clinics for over 15 visually impaired people with Hands On Tokyo. - Malaysia: Supporting GivingHub to provide 170 low-income families with health education and financial literacy workshops and 100 cancer screening and consultation sessions. - The Philippines: Helping 100 university students transition into the workforce with financial literacy, career readiness, and future-of-work skills with Junior Achievement Philippines. - Singapore: Supporting 50 children with chronic illnesses and their caregivers through a fun-filled carnival experience with Club Rainbow (Singapore), bringing together families, caregivers and volunteers to foster inclusion and community spirit. - Thailand: Extending career readiness support for seven disadvantaged Thai youth via hospitality training scholarships with Pimali Foundation. Expanding the JA SparktheDream programme with Junior Achievement Thailand to enable another 30 Thai educators to deliver engaging financial literacy education for students by equipping them with knowledge, tools, and teaching skills. - Vietnam: Empowering 800 students to make better financial decisions through workshops and debate competitions by Startup Vietnam Foundation and Dear Our Community to build financial literacy, critical thinking, and communication skills. Providing schools in Vietnam's Khanh Hoa Province with 76 computers through Little Roses Foundation to enable 1,800 students to continue learning after damages from severe flooding. About FWD Group FWD Group (1828.HK) is a pan-Asian life and health insurance business that serves approximately 40 million customers across 10 markets, including BRI Life in Indonesia. FWD’s customer-led and tech-enabled approach aims to deliver innovative propositions, easy-to-understand products and a simpler insurance experience. Established in 2013, the company operates in some of the fastest-growing insurance markets in the world with a vision of changing the way people feel about insurance. FWD Group is listed on the Hong Kong Stock Exchange under the stock code 1828. For more information, please visit www.fwd.com For media inquiries, please contact: [email protected] Source: